Yuhong Ning
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Epigenetics and DNA Methylation 6
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 2
- Molecular Biology Techniques and Applications 2
-
- Cancer Genomics and Diagnostics 8
- Co-authors
- Anjan Thakurta (4 shared papers)Anita K. Gandhi (4 shared papers)Rajesh Chopra (4 shared papers)Courtney G. Havens (2 shared papers)Jian Kang (2 shared papers)Anke Klippel (2 shared papers)Thomas O. Daniel (2 shared papers)Michelle F. Waldman (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (3 papers)British Journal of Haematology (2 papers)Molecular Cancer Therapeutics (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Yuhong Ning
18 papers receiving 1.1k citations
Yuhong Ning's Hit Papers
Peers
Comparison fields: 5 of 78
- Hematology 547
- Oncology 386
- Molecular Biology 837
- Genetics 109
- Cancer Research 111
Countries citing papers authored by Yuhong Ning
This map shows the geographic impact of Yuhong Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhong Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhong Ning more than expected).
Fields of papers citing papers by Yuhong Ning
This network shows the impact of papers produced by Yuhong Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhong Ning. The network helps show where Yuhong Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuhong Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate Hit paper breakdown → | 2013 | 457 |
| 2 | 2010 | 288 | |
| 3 | 2015 | 154 | |
| 4 | 2020 | 119 | |
| 5 | 2016 | 40 | |
| 6 | 2013 | 37 | |
| 7 | 2018 | 28 | |
| 8 | 2024 | 10 | |
| 9 | 2024 | 9 | |
| 10 | 2009 | 6 | |
| 11 | 2013 | 3 | |
| 12 | 2021 | 3 | |
| 13 | 2009 | 2 | |
| 14 | 2021 | 1 | |
| 15 | The laboratory information management system (LIMS) for handling the heterogeneous data from high throughput experiments in the post-genome sequencing era | 2004 | 1 |
| 16 | 2019 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2010 | 1 | |
| 19 | 2021 | 0 |
About Yuhong Ning
Yuhong Ning is a scholar working on Molecular Biology, Cancer Research, Hematology, Oncology and Infectious Diseases, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Epigenetics and DNA Methylation (6 papers), Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Acute Myeloid Leukemia Research (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Hematology (547 citations), Oncology (386 citations), Molecular Biology (837 citations), Genetics (109 citations) and Cancer Research (111 citations). Yuhong Ning has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Anjan Thakurta, Anita K. Gandhi, Rajesh Chopra, Courtney G. Havens, Jian Kang, Anke Klippel, Thomas O. Daniel, Michelle F. Waldman, Peter Schäfer and Thomas A. Conklin. Their work appears in journals such as Journal of Clinical Oncology, Blood, British Journal of Haematology, Molecular Cancer Therapeutics and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.